These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 25916568

  • 1. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N, Sato N, Oikawa K, Karim Talib A, Sugiyama E, Minoshima A, Tanabe Y, Takeuchi T, Akasaka K, Saijo Y, Kawamura Y, Hasebe N.
    Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
    [Abstract] [Full Text] [Related]

  • 2. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A, Hindieh W, Spears DA, Adler A, Rakowski H, Chan RH.
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [Abstract] [Full Text] [Related]

  • 3. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
    Spinner JA, Noel CV, Denfield SW, Krishnamurthy R, Jeewa A, Dreyer WJ, Maskatia SA.
    Am J Cardiol; 2016 Apr 15; 117(8):1342-8. PubMed ID: 26892450
    [Abstract] [Full Text] [Related]

  • 4. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY, Su MY, Chen JJ, Lai LP, Hwang JJ, Tseng CD, Chen YS, Yu HY, Tseng WY, Lin JL.
    JACC Cardiovasc Imaging; 2013 Nov 15; 6(11):1152-9. PubMed ID: 24229767
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS.
    Circ Cardiovasc Imaging; 2012 Jan 15; 5(1):78-85. PubMed ID: 22135401
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM.
    J Cardiovasc Electrophysiol; 2016 May 15; 27(5):571-80. PubMed ID: 26840595
    [Abstract] [Full Text] [Related]

  • 9. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P, Klimeczek P, Vliegenthart R, Pasowicz M, Miszalski-Jamka T, Oudkerk M, Podolec P, Dubiel JS, Tracz W.
    Kardiol Pol; 2009 Aug 15; 67(8A):964-9. PubMed ID: 19784900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
    Hen Y, Iguchi N, Machida H, Takada K, Utanohara Y, Sumiyoshi T.
    Heart Vessels; 2013 Nov 15; 28(6):742-9. PubMed ID: 23097076
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A, Kanzaki H, Noguchi T, Morita Y, Sugano Y, Ohara T, Hasegawa T, Hashimura H, Ishibashi-Ueda H, Kitakaze M, Yasuda S, Ogawa H, Anzai T.
    Heart Vessels; 2016 May 15; 31(5):758-70. PubMed ID: 25820658
    [Abstract] [Full Text] [Related]

  • 13. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D, Kosuge H, Terashima M, Koyama N, Kishida T, Tada Y, Suzuki JI, Sasano T, Ashikaga T, Hirao K, Isobe M.
    Heart Vessels; 2018 May 15; 33(5):513-520. PubMed ID: 29168014
    [Abstract] [Full Text] [Related]

  • 14. Late Gadolinium Enhancement on Cardiac MRI Correlates with QT Dynamicity Represented by QT/RR Relationship in Patients with Ventricular Arrhythmias.
    Sakamoto N, Sato N, Talib AK, Sugiyama E, Minoshima A, Tanabe Y, Fujino T, Takeuchi T, Akasaka K, Saijo Y, Kawamura Y, Hasebe N.
    Ann Noninvasive Electrocardiol; 2016 Mar 15; 21(2):126-35. PubMed ID: 26104916
    [Abstract] [Full Text] [Related]

  • 15. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.
    Mavrogeni S, Petrou E, Kolovou G, Theodorakis G, Iliodromitis E.
    Eur Heart J Cardiovasc Imaging; 2013 Jun 15; 14(6):518-25. PubMed ID: 23324829
    [Abstract] [Full Text] [Related]

  • 16. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L, Xu HY, Zheng SS, Zhu Y, Xiao JX, Zhou W, Yu SS, Gong LG.
    Int J Cardiovasc Imaging; 2017 Dec 15; 33(12):1949-1959. PubMed ID: 28612277
    [Abstract] [Full Text] [Related]

  • 17. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T, Ghasabeh MA, Assis FR, Chrispin J, Keramati A, Misra S, Berger R, Calkins H, Kamel I, Nazarian S, Zimmerman S, Tandri H.
    Circ Cardiovasc Imaging; 2018 Sep 15; 11(9):e007546. PubMed ID: 30354675
    [Abstract] [Full Text] [Related]

  • 18. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW, Kim HK.
    Heart; 2015 Jun 15; 101(11):870-6. PubMed ID: 25897040
    [Abstract] [Full Text] [Related]

  • 19. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.
    J Cardiovasc Magn Reson; 2009 Sep 09; 11(1):34. PubMed ID: 19740409
    [Abstract] [Full Text] [Related]

  • 20. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.
    Rev Esp Cardiol; 2007 Jan 09; 60(1):15-23. PubMed ID: 17288951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.